![Elizabeth J. Linder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Elizabeth J. Linder
Direttore/Membro del Consiglio presso Asia Scotland Initiative
Posizioni attive di Elizabeth J. Linder
Società | Posizione | Inizio | Fine |
---|---|---|---|
Asia Scotland Initiative
![]() Asia Scotland Initiative Miscellaneous Commercial ServicesCommercial Services Asia Scotland Initiative promotes understanding and collaboration between Scotland and Asia. The company was founded by Roddy Gow and is headquartered in Edinburgh, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Elizabeth J. Linder
Statistiche
Distribuzione geografica
Regno Unito | 2 |
Svizzera | 2 |
Posizioni
Director/Board Member | 2 |
Settori
Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Asia Scotland Initiative
![]() Asia Scotland Initiative Miscellaneous Commercial ServicesCommercial Services Asia Scotland Initiative promotes understanding and collaboration between Scotland and Asia. The company was founded by Roddy Gow and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Elizabeth J. Linder
- Esperienza